Efficacy and safety of apremilast in patients with moderate-to-severe plaque psoriasis of the scalp: results up to 32 weeks from a randomized, phase III study

A. S. Van Voorhees, L. Stein Gold, M. Lebwohl, B. Strober, H. Sofen, K. Papp, J. Bagel, Z. Zhang, M. Paris, Y. Wang

Research output: Contribution to journalLetterpeer-review

4 Scopus citations
Original languageEnglish
Pages (from-to)840-842
Number of pages3
JournalBritish Journal of Dermatology
Issue number4
StatePublished - Oct 2021

Cite this